Immune control of HIV-1 after early treatment of acute infection (Q56961920)

Marcus Altfeld

0 references

Philip J. R. Goulder

Philip J. R. Goulder

0 references

Eric S Rosenberg

Eric S. Rosenberg

0 references

Gregory T Robbins

Gregory K. Robbins

0 references

author name string

Samuel H. Poon

0 references

Mary N. Phillips

0 references

Barbara M. Wilkes

0 references

Robert L. Eldridge

0 references

Richard T. D'Aquila

0 references

language of work or name

English

0 references

publication date

September 2000

0 references

number of pages

1 reference

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

inferred from page(s)

published in

Nature

0 references

volume

407

0 references

issue

6803

0 references

page(s)

523-526

0 references

cites work

1 reference

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

7 January 2021

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

7 January 2021

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

7 January 2021

Acute human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

1 reference

7 January 2021

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

7 January 2021

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

1 reference

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

7 January 2021

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

7 January 2021

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

1 reference

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

7 January 2021

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

1 reference

7 January 2021

Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.

1 reference

7 January 2021

Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing

1 reference

7 January 2021

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

7 January 2021